Back
Day Range
$20.90
$24.70
52-Week Range
$17.62
$28.10
Volume
92
50D / 200D Avg
$25.37
/
$25.54
Prev Close
$24.70
Quick Summary
Price History
Financial Trends
Peer Comparison
vs Healthcare sector median (627 peers)
| Metric | Stock | Sector Median |
|---|---|---|
| P/E | 91.9 | 0.3 |
| P/B | 4.4 | 3.0 |
| ROE % | 4.7 | 3.7 |
| Net Margin % | 3.3 | 3.8 |
| Rev Growth 5Y % | 7.0 | 10.0 |
| D/E | 0.5 | 0.2 |
Analyst Price Target
No analyst coverage available
Earnings Estimates
| Period | EPS Est. | Revenue Est. | Analysts |
|---|---|---|---|
| FY2028 |
$1.09
$1.06 – $1.13
|
288.12M | 1 |
| FY2027 |
$0.97
$0.95 – $1.01
|
268.99M | 1 |
| FY2026 |
$0.87
$0.84 – $0.90
|
251.36M | 1 |
No quarterly estimates available
Earnings Surprises
Last 8 quarters
| Quarter | Est. EPS | Actual EPS | Surprise |
|---|---|---|---|
| 2025-11-12 | $0.48 | $0.26 | -44.3% |
| 2025-05-21 | $0.30 | $0.08 | -74.4% |
| 2024-11-19 | $0.43 | $0.07 | -84.3% |
| 2024-05-21 | N/A | -$0.02 | — |
| 2024-02-08 | N/A | -$0.43 | — |
| 2023-03-30 | N/A | -$0.14 | — |
| 2022-09-30 | $0.55 | $0.15 | -73.6% |
| 2022-03-30 | $0.23 | -$0.50 | -315.1% |
Dividend History
Yield
0.01%
Payout Ratio
N/A
Growth (3Y)
N/A
Growth (5Y)
N/A
| Ex-Date | Payment Date | Amount | Yield |
|---|---|---|---|
| Feb 06, 2026 | Mar 06, 2026 | $0.17 | 0.92% |
| Aug 08, 2025 | Sep 05, 2025 | $0.08 | 0.91% |
| Feb 07, 2025 | Mar 07, 2025 | $0.16 | 1.29% |
| Aug 09, 2024 | Sep 06, 2024 | $0.07 | 1.50% |
| Feb 08, 2024 | Mar 08, 2024 | $0.15 | 3.03% |
| Aug 10, 2023 | Sep 08, 2023 | $0.14 | 4.06% |
| Feb 09, 2023 | Mar 10, 2023 | $0.31 | 3.45% |
| Aug 04, 2022 | Sep 02, 2022 | $0.14 | 3.39% |
| Feb 10, 2022 | Mar 11, 2022 | $0.31 | 3.11% |
| Aug 05, 2021 | Sep 03, 2021 | $0.14 | 1.02% |
| Feb 11, 2021 | Mar 12, 2021 | $0.25 | 0.85% |
| Aug 06, 2020 | Sep 04, 2020 | $0.12 | 0.78% |
| Feb 13, 2020 | Mar 13, 2020 | $0.18 | 1.08% |
| Aug 08, 2019 | Sep 06, 2019 | $0.08 | 1.14% |
| Feb 14, 2019 | Mar 15, 2019 | $0.14 | 1.24% |
| Aug 09, 2018 | Sep 07, 2018 | $0.07 | 1.03% |
| Feb 15, 2018 | Mar 16, 2018 | $0.12 | 0.99% |
| Aug 10, 2017 | Sep 08, 2017 | $0.05 | 1.02% |
| Feb 16, 2017 | Mar 17, 2017 | $0.08 | 1.00% |
| Aug 04, 2016 | Sep 05, 2016 | $0.04 | 0.83% |
Key Takeaways
Revenue grew 7.01% annually over 5 years — modest growth
Earnings grew 162.77% over the past year
ROE of 4.74% is below average
Debt/Equity of 0.49 — conservative balance sheet
Generating 15.65M in free cash flow
P/E of 91.85 — premium valuation
Growth
Revenue Growth (5Y)
7.01%
Revenue (1Y)-12.64%
Earnings (1Y)162.77%
FCF Growth (3Y)N/A
Quality
Return on Equity
4.74%
ROIC7.09%
Net Margin3.28%
Op. Margin9.75%
Safety
Debt / Equity
0.49
Current Ratio2.39
Interest Coverage5.19
Valuation
P/E Ratio
91.85
Forward P/EN/A
P/B Ratio4.35
EV/EBITDA33.82
Dividend Yield0.01%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | -12.64% | Revenue Growth (3Y) | -0.73% |
| Earnings Growth (1Y) | 162.77% | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | 7.01% | Earnings Growth (5Y) | N/A |
| Profitability | |||
| Revenue (TTM) | 240.24M | Net Income (TTM) | 7.88M |
| ROE | 4.74% | ROA | 2.51% |
| Gross Margin | 41.00% | Operating Margin | 9.75% |
| Net Margin | 3.28% | Free Cash Flow (TTM) | 15.65M |
| ROIC | 7.09% | FCF Growth (3Y) | N/A |
| Safety | |||
| Debt / Equity | 0.49 | Current Ratio | 2.39 |
| Interest Coverage | 5.19 | ||
| Dividends | |||
| Dividend Yield | 0.01% | Payout Ratio | N/A |
| Dividend Growth (3Y) | N/A | Dividend Growth (5Y) | N/A |
| Consecutive Div Years | N/A | ||
| Valuation | |||
| P/E Ratio | 91.85 | Forward P/E | N/A |
| P/B Ratio | 4.35 | P/S Ratio | 3.01 |
| PEG Ratio | 0.62 | Forward PEG | N/A |
| EV/EBITDA | 33.82 | Fwd EV/EBITDA | N/A |
| Forward P/S | N/A | Fwd Earnings Yield | N/A |
| FCF Yield | 2.16% | ||
| Market Cap | 724.04M | Enterprise Value | 791.94M |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 240.24M | 275.00M | 243.80M | 228.58M | 183.22M |
| Net Income | 7.88M | 3.00M | -14.40M | -6.81M | -25.28M |
| EPS (Diluted) | 0.26 | 0.10 | -0.48 | -0.25 | -0.83 |
| Gross Profit | 98.50M | 105.80M | 85.90M | 66.10M | 59.83M |
| Operating Income | 23.42M | 10.70M | -12.60M | 9.85M | -7.38M |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 314.32M | 312.90M | 348.10M | 344.90M | 399.42M |
| Total Liabilities | 147.87M | 146.40M | 188.70M | 136.28M | 193.65M |
| Shareholders' Equity | 166.45M | 166.50M | 159.40M | 210.50M | 205.77M |
| Total Debt | 81.28M | 79.40M | 98.60M | 77.50M | 70.13M |
| Cash & Equivalents | 13.38M | 14.00M | 13.20M | 9.50M | 14.13M |
| Current Assets | 121.02M | 106.30M | 126.20M | 110.10M | 129.13M |
| Current Liabilities | 50.72M | 46.90M | 40.00M | 47.10M | 47.59M |